-
1
-
-
33750591177
-
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review
-
Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20:2165-74.
-
(2006)
AIDS
, vol.20
, pp. 2165-2174
-
-
Brown, T.T.1
Qaqish, R.B.2
-
2
-
-
84880210641
-
Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapynaive HIV-1-infected individuals
-
Brown TT, Chen Y, Currier JS, et al. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapynaive HIV-1-infected individuals. J Acquir Immune Defic Syndr 2013; 63:323-30.
-
(2013)
J Acquir Immune Defic Syndr
, vol.63
, pp. 323-330
-
-
Brown, T.T.1
Chen, Y.2
Currier, J.S.3
-
4
-
-
0041322965
-
AGA technical review on osteoporosis in hepatic disorders
-
Leslie WD, Bernstein CN, Leboff MS. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 2003; 125:941-66.
-
(2003)
Gastroenterology
, vol.125
, pp. 941-966
-
-
Leslie, W.D.1
Bernstein, C.N.2
Leboff, M.S.3
-
5
-
-
68449093191
-
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir
-
van Vonderen MG, Lips P, van Agtmael MA, et al. First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS 2009; 23:1367-76.
-
(2009)
AIDS
, vol.23
, pp. 1367-1376
-
-
Van Vonderen, M.G.1
Lips, P.2
Van Agtmael, M.A.3
-
6
-
-
77957847133
-
Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study
-
Stellbrink HJ, Orkin C, Arribas JR, et al. Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 2010; 51:963-72.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 963-972
-
-
Stellbrink, H.J.1
Orkin, C.2
Arribas, J.R.3
-
7
-
-
79957494036
-
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavirlamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS clinical trials group A5224s, a substudy of ACTG A5202
-
McComsey GA, Kitch D, Daar ES, et al. Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavirlamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis 2011; 203:1791-801.
-
(2011)
J Infect Dis
, vol.203
, pp. 1791-1801
-
-
McComsey, G.A.1
Kitch, D.2
Daar, E.S.3
-
8
-
-
79951930013
-
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans
-
Womack JA, Goulet JL, Gibert C, et al. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One 2011; 6:e17217.
-
(2011)
PLoS One
, vol.6
, pp. e17217
-
-
Womack, J.A.1
Goulet, J.L.2
Gibert, C.3
-
9
-
-
79953877822
-
Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000-2006
-
Young B, Dao CN, Buchacz K, Baker R, Brooks JT. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 2011; 52:1061-8.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 1061-1068
-
-
Young, B.1
Dao, C.N.2
Buchacz, K.3
Baker, R.4
Brooks, J.T.5
-
10
-
-
84868191819
-
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection
-
Lo Re V 3rd, Volk J, Newcomb CW, et al. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology 2012; 56:1688-98.
-
(2012)
Hepatology
, vol.56
, pp. 1688-1698
-
-
Lo Re, V.1
Volk, J.2
Newcomb, C.W.3
-
11
-
-
36148939489
-
The association of bone mineral density with HIV infection and antiretroviral treatment in women
-
Anastos K, Lu D, Shi O, et al. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther 2007; 12:1049-58.
-
(2007)
Antivir Ther
, vol.12
, pp. 1049-1058
-
-
Anastos, K.1
Lu, D.2
Shi, O.3
-
12
-
-
75149164256
-
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men
-
Lo Re V 3rd, Guaraldi G, Leonard MB, et al. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 2009; 23:2191-8.
-
(2009)
AIDS
, vol.23
, pp. 2191-2198
-
-
Lo Re, V.1
Guaraldi, G.2
Leonard, M.B.3
-
13
-
-
76149121133
-
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women
-
Yin MT, McMahon DJ, Ferris DC, et al. Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J Clin Endocrinol Metab 2010; 95:620-9.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 620-629
-
-
Yin, M.T.1
McMahon, D.J.2
Ferris, D.C.3
-
14
-
-
84876395424
-
Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 aquitaine cohort
-
Lawson-Ayayi S, Cazanave C, Kpozehouen A, et al. Chronic viral hepatitis is associated with low bone mineral density in HIV-infected patients, ANRS CO 3 Aquitaine Cohort. J Acquir Immune Defic Syndr 2013; 62:430-5.
-
(2013)
J Acquir Immune Defic Syndr
, vol.62
, pp. 430-435
-
-
Lawson-Ayayi, S.1
Cazanave, C.2
Kpozehouen, A.3
-
15
-
-
77957855493
-
Bone disease in HIV infection: A practical review and recommendations for HIV care providers
-
McComsey GA, Tebas P, Shane E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010; 51:937-46.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 937-946
-
-
McComsey, G.A.1
Tebas, P.2
Shane, E.3
-
16
-
-
0037169482
-
Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha
-
Gilbert L, He X, Farmer P, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 2002; 277:2695-701.
-
(2002)
J Biol Chem
, vol.277
, pp. 2695-2701
-
-
Gilbert, L.1
He, X.2
Farmer, P.3
-
17
-
-
0035881606
-
Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption
-
Radeff JM, Nagy Z, Stern PH. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Exp Cell Res 2001; 268:179-88.
-
(2001)
Exp Cell Res
, vol.268
, pp. 179-188
-
-
Radeff, J.M.1
Nagy, Z.2
Stern, P.H.3
-
18
-
-
63249097617
-
Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis
-
Kontulainen SA, Johnston JD, Liu D, Leung C, Oxland TR, McKay HA. Strength indices from pQCT imaging predict up to 85% of variance in bone failure properties at tibial epiphysis and diaphysis. J Musculoskelet Neuronal Interact 2008; 8:401-9.
-
(2008)
J Musculoskelet Neuronal Interact
, vol.8
, pp. 401-409
-
-
Kontulainen, S.A.1
Johnston, J.D.2
Liu, D.3
Leung, C.4
Oxland, T.R.5
McKay, H.A.6
-
19
-
-
34249998971
-
Tibial geometry is associated with failure load ex vivo: A MRI, pQCT and DXA study
-
Liu D, Manske SL, Kontulainen SA, et al. Tibial geometry is associated with failure load ex vivo: a MRI, pQCT and DXA study. Osteoporos Int 2007; 18:991-7.
-
(2007)
Osteoporos Int
, vol.18
, pp. 991-997
-
-
Liu, D.1
Manske, S.L.2
Kontulainen, S.A.3
-
20
-
-
59849116507
-
Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease
-
Dubner SE, Shults J, Baldassano RN, et al. Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 2009; 136:123-30.
-
(2009)
Gastroenterology
, vol.136
, pp. 123-130
-
-
Dubner, S.E.1
Shults, J.2
Baldassano, R.N.3
-
21
-
-
84881528941
-
Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease
-
Tsampalieros A, Lam CK, Spencer JC, et al. Long-term inflammation and glucocorticoid therapy impair skeletal modeling during growth in childhood Crohn disease. J Clin Endocrinol Metab 2013; 98: 3438-45.
-
(2013)
J Clin Endocrinol Metab
, vol.98
, pp. 3438-3445
-
-
Tsampalieros, A.1
Lam, C.K.2
Spencer, J.C.3
-
22
-
-
79959909975
-
Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: A cross-sectional study
-
Aeberli D, Eser P, Bonel H, et al. Reduced trabecular bone mineral density and cortical thickness accompanied by increased outer bone circumference in metacarpal bone of rheumatoid arthritis patients: a cross-sectional study. Arthritis Res Ther 2010; 12:R119.
-
(2010)
Arthritis Res Ther
, vol.12
, pp. R119
-
-
Aeberli, D.1
Eser, P.2
Bonel, H.3
-
23
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62.
-
(1999)
N Engl J Med
, vol.341
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
-
24
-
-
0037087144
-
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group
-
Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-7.
-
(2002)
Clin Infect Dis
, vol.34
, pp. 831-837
-
-
Sherman, K.E.1
Rouster, S.D.2
Chung, R.T.3
Rajicic, N.4
-
25
-
-
29244465093
-
Bone disease and HIV infection
-
Amorosa V, Tebas P. Bone disease and HIV infection. Clin Infect Dis 2006; 42:108-14.
-
(2006)
Clin Infect Dis
, vol.42
, pp. 108-114
-
-
Amorosa, V.1
Tebas, P.2
-
26
-
-
54849417200
-
Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy
-
Hofmann WP, Kronenberger B, Bojunga J, et al. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat 2008; 15:790-6.
-
(2008)
J Viral Hepat
, vol.15
, pp. 790-796
-
-
Hofmann, W.P.1
Kronenberger, B.2
Bojunga, J.3
-
27
-
-
84871498149
-
Associations between body composition and bone density and structure in men and women across the adult age spectrum
-
Baker JF, Davis M, Alexander R, et al. Associations between body composition and bone density and structure in men and women across the adult age spectrum. Bone 2013; 53:34-41.
-
(2013)
Bone
, vol.53
, pp. 34-41
-
-
Baker, J.F.1
Davis, M.2
Alexander, R.3
-
28
-
-
0028088313
-
Screening with the Alcohol use disorders identification test (AUDIT) in an inner-city population
-
Isaacson JH, Butler R, Zacharek M, Tzelepis A. Screening with the Alcohol use Disorders Identification Test (AUDIT) in an inner-city population. J Gen Intern Med 1994; 9:550-3.
-
(1994)
J Gen Intern Med
, vol.9
, pp. 550-553
-
-
Isaacson, J.H.1
Butler, R.2
Zacharek, M.3
Tzelepis, A.4
-
29
-
-
0032517042
-
The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test
-
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998; 158:1789-95.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1789-1795
-
-
Bush, K.1
Kivlahan, D.R.2
McDonell, M.B.3
Fihn, S.D.4
Bradley, K.A.5
-
30
-
-
0036840537
-
Multi-ethnic study of atherosclerosis: Objectives and design
-
Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156: 871-81.
-
(2002)
Am J Epidemiol
, vol.156
, pp. 871-881
-
-
Bild, D.E.1
Bluemke, D.A.2
Burke, G.L.3
-
31
-
-
0033822207
-
Compendium of physical activities: An update of activity codes and MET intensities
-
Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32(Suppl 9):S498-504.
-
(2000)
Med Sci Sports Exerc
, vol.32
, pp. S498-504
-
-
Ainsworth, B.E.1
Haskell, W.L.2
Whitt, M.C.3
-
32
-
-
0029778988
-
An algorithm for the grading of activity in chronic hepatitis C: The METAVIR cooperative study group
-
Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C: the METAVIR Cooperative Study Group. Hepatology 1996; 24:289-93.
-
(1996)
Hepatology
, vol.24
, pp. 289-293
-
-
Bedossa, P.1
Poynard, T.2
-
33
-
-
12344267742
-
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
-
Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004; 3:8.
-
(2004)
Comp Hepatol
, vol.3
, pp. 8
-
-
Poynard, T.1
Imbert-Bismut, F.2
Munteanu, M.3
-
34
-
-
25444434632
-
Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection
-
Adams LA, Bulsara M, Rossi E, et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005; 51:1867-73.
-
(2005)
Clin Chem
, vol.51
, pp. 1867-1873
-
-
Adams, L.A.1
Bulsara, M.2
Rossi, E.3
-
36
-
-
2942561001
-
Interpretation of whole body dual energy x-ray absorptiometry measures in children: Comparison with peripheral quantitative computed tomography
-
Leonard MB, Shults J, Elliott DM, Stallings VA, Zemel BS. Interpretation of whole body dual energy x-ray absorptiometry measures in children: comparison with peripheral quantitative computed tomography. Bone 2004; 34:1044-52.
-
(2004)
Bone
, vol.34
, pp. 1044-1052
-
-
Leonard, M.B.1
Shults, J.2
Elliott, D.M.3
Stallings, V.A.4
Zemel, B.S.5
-
37
-
-
70349280466
-
Dual energy x-ray absorptiometry body composition reference values from NHANES
-
Kelly TL, Wilson KE, Heymsfield SB. Dual energy x-Ray absorptiometry body composition reference values from NHANES. PLoS One 2009; 4:e7038.
-
(2009)
PLoS One
, vol.4
, pp. e7038
-
-
Kelly, T.L.1
Wilson, K.E.2
Heymsfield, S.B.3
-
38
-
-
0018398914
-
-
Serum-calcium [editorial]
-
Serum-calcium [editorial]. Lancet 1979; 1:858-9.
-
(1979)
Lancet
, vol.1
, pp. 858-859
-
-
-
39
-
-
77952102785
-
A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: Application to Vitamin D testing
-
Hoofnagle AN, Laha TJ, Donaldson TF. A rubber transfer gasket to improve the throughput of liquid-liquid extraction in 96-well plates: application to vitamin D testing. J Chromatogr B Analyt 2010; 878:1639-42.
-
(2010)
J Chromatogr B Analyt
, vol.878
, pp. 1639-1642
-
-
Hoofnagle, A.N.1
Laha, T.J.2
Donaldson, T.F.3
-
40
-
-
80052255355
-
Quantification of 1alpha,25-dihydroxy Vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry
-
Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1alpha,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem 2011; 57:1279-85.
-
(2011)
Clin Chem
, vol.57
, pp. 1279-1285
-
-
Strathmann, F.G.1
Laha, T.J.2
Hoofnagle, A.N.3
-
41
-
-
84870380958
-
Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry
-
Laha TJ, Strathmann FG, Wang Z, de Boer IH, Thummel KE, Hoofnagle AN. Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry. Clin Chem 2012; 58:1711-6.
-
(2012)
Clin Chem
, vol.58
, pp. 1711-1716
-
-
Laha, T.J.1
Strathmann, F.G.2
Wang, Z.3
De Boer, I.H.4
Thummel, K.E.5
Hoofnagle, A.N.6
-
42
-
-
34447514029
-
Vitamin D deficiency
-
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357:266-81.
-
(2007)
N Engl J Med
, vol.357
, pp. 266-281
-
-
Holick, M.F.1
-
43
-
-
0025333948
-
The LMS method for constructing normalized growth standards
-
Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990; 44:45-60.
-
(1990)
Eur J Clin Nutr
, vol.44
, pp. 45-60
-
-
Cole, T.J.1
-
44
-
-
84874656322
-
Changes in bone structure and the muscle-bone unit in children with chronic kidney disease
-
Tsampalieros A, Kalkwarf HJ, Wetzsteon RJ, et al. Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int 2013; 83:495-502.
-
(2013)
Kidney Int
, vol.83
, pp. 495-502
-
-
Tsampalieros, A.1
Kalkwarf, H.J.2
Wetzsteon, R.J.3
-
45
-
-
0033695186
-
Inhibition of osteoblast differentiation by tumor necrosis factor-alpha
-
Gilbert L, He X, Farmer P, et al. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 2000; 141:3956-64.
-
(2000)
Endocrinology
, vol.141
, pp. 3956-3964
-
-
Gilbert, L.1
He, X.2
Farmer, P.3
-
46
-
-
0035965998
-
Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK
-
Lee SE, Chung WJ, Kwak HB, et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 2001; 276:49343-9.
-
(2001)
J Biol Chem
, vol.276
, pp. 49343-49349
-
-
Lee, S.E.1
Chung, W.J.2
Kwak, H.B.3
-
47
-
-
80052921809
-
Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection
-
El-Maouche D, Mehta SH, Sutcliffe C, et al. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol 2011; 55:770-6.
-
(2011)
J Hepatol
, vol.55
, pp. 770-776
-
-
El-Maouche, D.1
Mehta, S.H.2
Sutcliffe, C.3
-
48
-
-
84863618603
-
Hip bone geometry in HIV/HCV-co-infected men and healthy controls
-
Walker Harris V, Sutcliffe CG, Araujo AB, et al. Hip bone geometry in HIV/HCV-co-infected men and healthy controls. Osteoporos Int 2012; 23:1779-87.
-
(2012)
Osteoporos Int
, vol.23
, pp. 1779-1787
-
-
Walker Harris, V.1
Sutcliffe, C.G.2
Araujo, A.B.3
-
49
-
-
84878801404
-
Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women
-
Calmy A, Chevalley T, Delhumeau C, et al. Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women. Osteoporos Int 2013; 24:1843-52.
-
(2013)
Osteoporos Int
, vol.24
, pp. 1843-1852
-
-
Calmy, A.1
Chevalley, T.2
Delhumeau, C.3
-
50
-
-
84894044726
-
Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life
-
Yin MT, Lund E, Shah J, et al. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS 2014; 28:345-53.
-
(2014)
AIDS
, vol.28
, pp. 345-353
-
-
Yin, M.T.1
Lund, E.2
Shah, J.3
-
52
-
-
12444286800
-
Bone mineral and soft-tissue changes in AIDSassociated lipoatrophy
-
Rosenthall L, Falutz J Bone mineral and soft-tissue changes in AIDSassociated lipoatrophy. J Bone Miner Metab 2005; 23:53-7.
-
(2005)
J Bone Miner Metab
, vol.23
, pp. 53-57
-
-
Rosenthall, L.1
Falutz, J.2
-
53
-
-
34250893122
-
Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS clinical trials group study 384
-
Dube MP, Parker RA, Mulligan K, et al. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clin Infect Dis 2007; 45:120-6.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 120-126
-
-
Dube, M.P.1
Parker, R.A.2
Mulligan, K.3
-
54
-
-
12844273480
-
Changes in weight and lean body mass during highly active antiretroviral therapy
-
Shikuma CM, Zackin R, Sattler F, et al. Changes in weight and lean body mass during highly active antiretroviral therapy. Clin Infect Dis 2004; 39:1223-30.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 1223-1230
-
-
Shikuma, C.M.1
Zackin, R.2
Sattler, F.3
|